Brief: Neurotrope Concludes Data Collection In Phase 2 Clinical Trial Of Moderately Severe To Severe Alzheimer's Disease
15/07/2019 13:42
July 15 (Reuters) - Neurotrope Inc NTRP.O :
* NEUROTROPE CONCLUDES DATA COLLECTION IN CONFIRMATORY PHASE
2
CLINICAL TRIAL OF MODERATELY SEVERE TO SEVERE ALZHEIMER'S
DISEASE
* NEUROTROPE INC - TOP-LINE EFFICACY DATA EXPECTED TO BE
ANNOUNCED
DURING Q3 OF 2019
Source text for Eikon: ID:nPnfNfqTa
Further company coverage: NTRP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextTrip
See all newsBrief: Nexttrip - Announces Joint Venture With Ttand In Canada - SEC Filing
Nexttrip Inc reports results for the quarter ended August 31 - Earnings Summary
Nexttrip Inc expected to post a loss of 14 cents a share - Earnings Preview
Nexttrip Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: NextTrip Enters At-The-Market Offering Agreement With Titan Partners Securities On August 31